SLC5A2 and hydrops fetalis: However, in DAPA‐HF, the increase in haemoglobin with dapagliflozin tended to be smaller in patients who were iron deficient at baseline, raising the question of whether intravenous iron administration may help increase the benefits of SGLT2 inhibitors in iron deplete patients.5